Saint Louis University’s Jenna Gorlewicz, Ph.D., has been named to the St. Louis Business Journal’s prestigious 40 Under 40 list, recognizing her leadership in engineering, research, and community impact.
A group of researchers from WashU in the McKelvey School of Engineering and the School of Medicine have created a new kind of fiber-optic device to manipulate neural activity deep in the brain. The device, called PRIME fiber, delivers multi-site, reconfigurable optical stimulation through a single, hair-thin implant.
Dr. Eric Leuthardt, neurosurgeon, scientist, entrepreneur, and co-leader of NEURO360, is advancing neurotechnology in St. Louis by translating groundbreaking research into life-changing solutions, launching companies like Neurolutions and Aurenar, and building a city-wide neurotech ecosystem.
A $3.2M NIH grant will support groundbreaking AI-driven research by WashU’s Ganesh Chand, PhD, to uncover mechanisms behind neuropsychiatric symptoms in Alzheimer’s.
NEURO360 took center stage at the 2025 BioSTL Global Health Innovation Summit in St. Louis, featuring a half-day dedicated to neuroscience innovation. Panels, startup showcases, and translation-to-practice discussions highlighted St. Louis as an emerging global hub for brain health breakthroughs.
NEURO360 partner, C2N Diagnostics, is set to occupy just over half of the new space in WashU’s $100 million redevelopment, leaving room …
NEURO360 partner, Avadel Pharmaceuticals, is expanding its sleep medicine pipeline with a new potential therapy, valiloxybate for treatment of narcolepsy and idiopathic …
St. Louis Magazine highlights NEURO360’s vision to position St. Louis as a national leader in neuroscience and neurotechnology, uniting WashU, BioSTL, industry partners, and regional stakeholders to accelerate discovery, translation, workforce development, and community impact across the entire neuroscience ecosystem.
A randomized controlled trial has demonstrated clinically meaningful improvements in...
Read More
Researchers at Washington University in St. Louis are developing a...
Read More
A randomized controlled trial has demonstrated clinically meaningful improvements in...
Read More
By combining advanced vision-language AI models with real-world task analysis,...
Read More
By combining advanced vision-language AI models with real-world task analysis,...
Read More
Research from WashU Medicine reports encouraging long-term results for tofersen,...
Read More
Research at Washington University in St. Louis has been recognized...
Read More
NEURO360-aligned research led by Rohit V. Pappu, PhD, with Min...
Read More
ShiNung Ching, PhD, co-lead of NEURO360’s Mobile Apps, Software &...
Read More
NEURO360, BioSTL’s NSF Engines grant application with WashU, faced delays due to federal funding shifts—but we’re back on track. Our commitment to making St. Louis a leader in neuroscience innovation remains strong, regardless of the NSF outcome.
Women We Admire recently released their Top 50 Women Chief …
NEURO360, BioSTL’s NSF Engines grant application with WashU, faced delays due to federal funding shifts—but we’re back on track. Our commitment to making St. Louis a leader in neuroscience innovation remains strong, regardless of the NSF outcome.
NEURO360, BioSTL’s NSF Engines grant application with WashU, faced delays due to federal funding shifts—but we’re back on track. Our commitment to making St. Louis a leader in neuroscience innovation remains strong, regardless of the NSF outcome.
A new AI-based technology that rapidly maps the brain to …
Researchers at Washington University School of Medicine in St. Louis …
Saint Louis University (SLU) proudly announces the appointment of Jenna Gorlewicz, …
In a recent study, researchers at WashU Medicine found adverse …
After finishing up their own schoolwork, WashU students travel to …
When a person sustains an injury to the spinal cord, …
A $160 million grant proposal submitted last week could establish …
Highlights from the NEURO360 Symposium Tuesday, April 22, 2025 | …
